Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous side effects of bleomycin therapy.

Y Werner, B Törnberg

    Acta Dermato-Venereologica
    |January 1, 1976
    PubMed
    Summary

    Bleomycin treatment for malignant lesions can cause skin changes. Biopsies revealed epidermal squamous cell degeneration and lysis in patients experiencing skin redness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Membrane-coating granules in "dry" non-eczematous skin of patients with atopic dermatitis. A quantitative electron microscopic study.

    Acta dermato-venereologica·1987
    Same author

    Relationship between certain radiographic and biologic characteristics in breast cancer.

    Acta oncologica (Stockholm, Sweden)·1987
    Same author

    Diet and pancreatic cancer: a case-control study.

    American journal of epidemiology·1986
    Same author

    The water content of the stratum corneum in patients with atopic dermatitis. Measurement with the Corneometer CM 420.

    Acta dermato-venereologica·1986
    Same author

    X-ray microanalysis of psoriatic skin.

    The Journal of investigative dermatology·1985
    Same author

    Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis.

    Acta dermato-venereologica·1985

    Area of Science:

    • Dermatology
    • Oncology
    • Pathology

    Background:

    • Bleomycin is an antineoplastic agent used in cancer treatment.
    • Cutaneous side effects are known complications of bleomycin therapy.
    • Understanding the precise morphological changes is crucial for patient management.

    Purpose of the Study:

    • To investigate the histopathological changes in the skin of patients treated with bleomycin.
    • To correlate clinical skin reactions with microscopic findings.

    Main Methods:

    • Punch biopsies were obtained from erythematous skin areas of eight patients undergoing bleomycin treatment.
    • Histopathological examination of biopsy specimens focused on epidermal morphology.

    Main Results:

    • Significant changes were observed in the squamous cells of the epidermis.
    • These changes ranged from mild cellular degeneration to complete cell lysis.
    • Erythema correlated with these observed cellular alterations.

    Conclusions:

    • Bleomycin-induced skin toxicity primarily affects epidermal squamous cells.
    • The observed morphological changes provide a histopathological basis for bleomycin-induced skin reactions.
    • Further research may explore preventative or therapeutic strategies for these side effects.

    Related Experiment Videos